Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2-3)

Gynecologic Oncology

Volumn 111, Issue 1, 2008, Pages 9-12

  González Bosquet, Eduardo ^a   Esteva, Cristina ^a   Muñoz Almagro, Carmen ^a   Ferrer, Patricia ^a   Pérez, Miriam ^a   Lailla, Jose M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; High risk HPV types; HPV vaccine

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED INFECTION; PAPANICOLAOU TEST; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS ISOLATION;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 52049110458     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.06.012     Document Type: Article

References (17)

1. Wieland U., and Pfister H. Papillomaviruses in human pathology: epidemiology, pathogenesis and oncologic role. In: Gross G., and Barroso R. (Eds). Human papillomavirus infection: a clinical atlas (1997), Ullstein Mosby, Berlin 1-18
2. González Bosquet E., Torres A., Busquets M., Esteva C., Muñoz-Almagro M.C., and Lailla J.M. Prognostic factors for the development of vaginal intraepithelial neoplasia. Eur J Gynaecol Oncol 29 (2008) 43-45
3. Clifford G.M., Smith J.S., Plumier M., Muñoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. B J Cancer 88 (2003) 63-73
4. Vonka V., and Hamsíková E. Vaccines against human papillomaviruses-a major breakthrough in cancer prevention. Cent Eur J Public Health 15 (2007) 131-139
5. Muñoz N., Bosch F.X., Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
6. González Bosquet E., Muñoz Almagro M.C., Suñol M., and Lailla J.M. Cervical cancer and low-risk HPV; a case report. Eur J Gynaecol Oncol 27 (2006) 193-194
7. Dexeus S., Cararach M., and Dexeus D. The role of colposcopy in modern gynecology. Eur J Gynaec Oncol 23 (2002) 269-277
8. Carestiato F.N., Silva K.C., Dimetz T., Oliveira L.H., and Cavalcanti S.M. Prevalence of human papillomavirus infection in the genital tract determinated by hybrid capture assay. Braz J Infect Dis 10 (2006) 331-336
9. Ciotti M., Sesti F., Paba P., Benedetto A., Patrizi L., Criscuolo A., et al. Human papillomavirus (HPV) testing in the management of women with abnormal pap smears. Experience of a colposcopy referral clinic. Eur J Gynaec Oncol 25 (2004) 577-584
10. Rowe L.R., Aldeen W., and Bentz J.S. Prevalence and typing of HPV by hybrid capture in women with ASCUS, ASC-H and AGC on ThinPrep Pap test. Diagn Cytopathol 30 (2004) 426-432
11. González Bosquet E., Muñoz Almagro M.M., Mora I., Suñol M., Callejo J., and Lailla J.M. Prevalence of human papilloma virus infection of the uterine cervix in women with abnormal cervical cytology. Eur J Gynaecol Oncol 27 2 (2006) 135-138
12. Levert M., Clavel C., Graesslin O., Masure M., Birembaut P., Quereux C., et al. Human papillomavirus typing in routine cervical smears. Result from a series of 3778 patients. Gynecol Obstet Fertil 28 (2000) 722-728
13. Antonishyn N.A., Horsman G.B., Kelln R.A., Saggar J., and Severini A. The impact of the distribution of human papillomavirus types and associated high-risk lesions in a colposcopy population for monitoring vaccine efficacy. Arch Pathol Lab Med. 132 (2008) 54-60
14. Rousseau M.C., Villa L.L., Costa M.C., Abrahamowicz M., Rohan T.E., and Franco E. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Transm Dis. 30 (2003) 581-587
15. Crum C.P., Beach K.J., Hedley M.L., Yuan L., Lee K.R., Wright T.C., and Urban R.G. Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol. J Infect Dis. 189 (2004) 1348-1354
16. Clifford G.M., Gallus S., Herrero R., Muñoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 366 (2005) 991-998
17. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 (2006) 1247-1255